// App-Quantinova.ai

BSH2020‐PO‐088 : Adoption of rapid obinutuzumab infusions: real world experience

Researchers

Presenter

  • J. Cunningham

Principal Investigators

  • D. Sparksman

  • D. Gordon-Walker

  • A. Collins

  • N. Shah

Medical Centers

  • Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Follicular lymphoma

  • Lymphomas

Biomarkers

  • B-lymphocyte antigen CD20

Drug/Treatment

  • Obinutuzumab

  • Obinutuzumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved